Henan Tianfu Chemical Co., Ltd.
China
Product Name: dihydroergocristine mesylate
Price: $Inquiry/1kg $Inquiry/25kg $Inquiry/1000kg $Inquiry/10ton
Purity: 99.0%
Stocking Period: Inquiry
Contact: Anson

24730-10-7

24730-10-7 structure

Name: Dihydroergocristine mesylate
Chemical Name: dihydroergocristine mesylate
CAS Number: 24730-10-7
Molecular Formula: C₃₆H₄₅N₅O₈S
Molecular Weight: 707.83600
Catalog: analytical chemistry Standard Pharmacopoeia Standards and Magazine Standards
Create Date: 2018-06-09 15:32:06
Modify Date: 2024-01-14 06:03:58
Dihydroergocristine mesylate (DHEC mesylate) is a inhibitor of γ-secretase (GSI), reduces the production of the Alzheimer's disease amyloid-β peptides, binds directly to γ-secretase and Nicastrin with equilibrium dissociation constants (Kd) of 25.7 nM and 9.8 μM, respectively[1].

Name	dihydroergocristine mesylate
Synonyms	dihydroergocristine methanesulphonate DIHYDROERGOCRYSTINE METHANESULFONATE SALT dihydroergocristine methane sulfonate DIHYDROERGOCRISTINE METHANESULFONATE ERG OT ALKALOID,VASOC Dihydroergocristine mesilate 9,10-DihydroergocristineMethanesulfonate EINECS 246-434-6 dihydroergocristine methanesulfonate salt Dihydroergocristine mesylate,(5'α,10α)-9,10-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-trionemesylate PACAP 1-38 MFCD00153792 dihydroergocristinmesilat DIHYDROERGOCRISTINE MESYLATE dihydroergocristine

Description	Dihydroergocristine mesylate (DHEC mesylate) is a inhibitor of γ-secretase (GSI), reduces the production of the Alzheimer's disease amyloid-β peptides, binds directly to γ-secretase and Nicastrin with equilibrium dissociation constants (Kd) of 25.7 nM and 9.8 μM, respectively[1].
Related Catalog	Research Areas >> Neurological Disease
In Vitro	Dihydroergocristine (DHEC) (2-20 μM; 24 hours) has an IC50 value of 25 μM for inhibiting the activity of γ-secretase in T100 cells without affecting cell viability[1]. Dihydroergocristine (2-20 μM; 24 hours) inhibits cellular Aβ production and causes a dose-dependent accumulation of carboxy-terminal fragments of APP (APP-CTFs) in HEK293 and decreases γ-secretase activity in fibroblast cells[1]. Western Blot Analysis[1] Cell Line: WT HEK293 cells; Fibroblast cells Concentration: 2 μM, 5 μM, 10 μM, 20 μM Incubation Time: 24 hours Result: Increased APP-CTFs accumulation in a dose-dependent manner.
References	[1]. Lei X, et al. The FDA-approved natural product dihydroergocristine reduces the production of the Alzheimer's disease amyloid-β peptides. Sci Rep. 2015 Nov 16;5:16541.

Boiling Point	899.3ºC at 760 mmHg
Molecular Formula	C₃₆H₄₅N₅O₈S
Molecular Weight	707.83600
Flash Point	497.7ºC
Exact Mass	707.29900
PSA	180.96000
LogP	3.50660
Vapour Pressure	8.49E-35mmHg at 25°C
Storage condition	Store at RT
Water Solubility	H2O: 10 mg/mL

CHEMICAL IDENTIFICATION

RTECS NUMBER :: KE7600000

CHEMICAL NAME :: Ergotamane-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(pheny lmethyl)-, (5'-alpha,10-alpha)-, monomethanesulfonate (salt)

CAS REGISTRY NUMBER :: 24730-10-7

LAST UPDATED :: 199703

DATA ITEMS CITED :: 8

MOLECULAR FORMULA :: C35-H41-N5-O5.C-H4-O3-S

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 2643 mg/kg

TOXIC EFFECTS :: Behavioral - general anesthetic Behavioral - tremor Behavioral - convulsions or effect on seizure threshold

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,1381,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 585 mg/kg

TOXIC EFFECTS :: Behavioral - general anesthetic Behavioral - tremor Behavioral - convulsions or effect on seizure threshold

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,1381,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 91 mg/kg

TOXIC EFFECTS :: Behavioral - general anesthetic Behavioral - tremor Behavioral - convulsions or effect on seizure threshold

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,1381,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >2500 mg/kg

TOXIC EFFECTS :: Behavioral - general anesthetic Behavioral - tremor Behavioral - convulsions or effect on seizure threshold

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,1381,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 120 mg/kg

TOXIC EFFECTS :: Behavioral - general anesthetic Behavioral - tremor Behavioral - convulsions or effect on seizure threshold

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,1381,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 70 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4176182

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: >1250 mg/kg

TOXIC EFFECTS :: Behavioral - tremor Behavioral - excitement Gastrointestinal - nausea or vomiting

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,1381,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: >50 mg/kg

TOXIC EFFECTS :: Behavioral - tremor Behavioral - excitement Gastrointestinal - nausea or vomiting

REFERENCE :: ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,1381,1992

RIDADR	UN 1544 6
WGK Germany	2
RTECS	KE7600000
Packaging Group	III
Hazard Class	6.1(b)

24730-10-7	487-79-6
102489-75-8	17479-19-5
441045-17-6	871348-24-2
202914-84-9	202464-88-8
157322-83-3	144143-96-4
1158522-08-7	1806602-72-1
1803959-83-2	1361554-21-3
1805087-23-3	1261655-42-8
1897590-93-0	1361744-27-5
940364-43-2	2228889-48-1